杨振军团队在环二鸟苷酸及其类似物的体内递送及肿瘤免疫作用机制研究方面取得新进展

中国药学(英文版) ›› 2022, Vol. 31 ›› Issue (10): 799-799.

杨振军团队在环二鸟苷酸及其类似物的体内递送及肿瘤免疫作用机制研究方面取得新进展

北京大学药学院天然药物及仿生药物国家重点实验室

北京大学药学院天然药物及仿生药物国家重点实验室

收稿日期:2022-10-26 修回日期:2022-10-26 接受日期:2022-10-26 出版日期:2022-10-31 发布日期:2022-11-12

The team of Prof. Zhenjun Yang has made new progress in the in vivo delivery of c-di-GMP and its analogues and the mechanism of tumor immunity

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2022-10-26 Revised:2022-10-26 Accepted:2022-10-26 Online:2022-10-31 Published:2022-11-12

摘要/Abstract

摘要： 杨振军团队在环二鸟苷酸及其类似物的体内递送及肿瘤免疫作用机制研究方面取得新进展.

Supporting:

北京大学药学院天然药物及仿生药物国家重点实验室. 杨振军团队在环二鸟苷酸及其类似物的体内递送及肿瘤免疫作用机制研究方面取得新进展[J]. 中国药学(英文版), 2022, 31(10): 799-799.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The team of Prof. Zhenjun Yang has made new progress in the in vivo delivery of c-di-GMP and its analogues and the mechanism of tumor immunity[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(10): 799-799.